IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Dodgy Ticker who wrote (1741)	12/29/2002 5:34:20 PM
From: Maurice Winn	1 Recommendation of 1762

Thanks Robert, I hadn't seen it. I tried reading it but there are weasel words and carefully crafted phraseology throughout, with the underlying theme being "We will give permission if we feel like it". That sentence <The FDA strongly supports expanded use of promising therapies for serious and otherwise untreatable diseases> could be interpreted as "The FDA strongly opposes any use of unpromising therapies for serious diseases for which we have already approved a treatment". Which of course means they decide what is promising and unpromising and no change to CHOP is allowed unless they give their blessing. One could not, of one's one volition, throw in some Rituxan and maybe a shot of Oncolym after the regular CHOP programme is finished, just to mop up any sneaky little blighters who escaped the toxic carnage of CHOP and were flaunting their CD20 antigens, laughing at the patient for being gullible. Such a plan would not be seen as promising. Too irregular old chap. Mqurice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next